Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services, LLC is recalling prenatal multivitamin tablets that may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling 2,299 Propranolol HCL 10 mg tablets due to potential mislabeling as other medications.
Aidapak Services, LLC is recalling Letrozole 2.5 mg tablets that may be mislabeled as Metoprolol Tartrate 50 mg. The error could lead to patients receiving the wrong medication.
Specialty Medicine Compounding Pharmacy is recalling Potassium Phosphate injectable products because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling Fluorouracil PF 50 mg/mL injectable because sterility cannot be assured after another product was found non-sterile in the same environment.
Aidapak Services, LLC is recalling Hydrocodone Bitartrate/Acetaminophen tablets because they may be mislabeled as Melatonin. The recall covers repacked drugs distributed in four western states.
Aidapak Services is recalling Hyoscyamine Sulfate tablets because they may be mislabeled as Azathioprine or Cholecalciferol.
Aidapak Services, LLC is recalling multivitamin tablets that may be mislabeled as lisinopril. The error could lead to patients taking the wrong medication.
Specialty Medicine Compounding Pharmacy is recalling Ceftazidime ophthalmic solution because sterility cannot be assured due to shared compounding practices with a non-sterile product.
Specialty Medicine Compounding Pharmacy is recalling Testos Cypionate injectable because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling EDETATE DISODIUM ophthalmic solution because sterility cannot be assured due to shared compounding practices with a non-sterile product.
Aidapak Services is recalling Aspirin tablets that may be mislabeled as Cholecalciferol. The FDA classifies this as a Class II recall.
Specialty Medicine Compounding Pharmacy is recalling sodium tetradecyl sulfate injectable because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling methylcobalamin injectable products because sterility cannot be assured after a related product was found to be non-sterile.
The Compounding Center at Blue Ridge is recalling all lots of Papaverine/Phentolamine injections due to quality control concerns regarding sterility assurance identified during an FDA inspection.
The Compounding Center at Blue Ridge is recalling PGE 20 mcg/mL and 40 mcg/mL injectables due to quality control concerns regarding sterility assurance identified during an FDA inspection.
The Compounding Center at Blue Ridge is recalling all lots of Quad Mix Injectable due to quality control concerns identified during an FDA inspection.
The Compounding Center at Blue Ridge is recalling 92 units of Triple Mix Injectable due to quality control concerns identified during an FDA inspection.
Watson Laboratories is recalling 4,439 bottles of Carisoprodol Tablets because metal particulates were visually observed in the tablets.
The FDA is recalling all lots of Super Triple Mix Injectable from The Compounding Center at Blue Ridge due to quality control concerns regarding sterility assurance.
Hospira Inc. is recalling 65,109 vials of Bupivacaine Hydrochloride with Epinephrine due to a potential breach in the aseptic process caused by equipment failure.
Teva Pharmaceuticals USA is recalling specific lots of Daunorubicin Hydrochloride Injection because the drug product contains precipitate.
Sandoz Incorporated is recalling specific lots of Tacrolimus Capsules because trace amounts of fluvastatin were found in the product.
GlaxoSmithKline is recalling 10,469 Imitrex STATdose Systems because some syringes may have needles protruding through the shield, compromising sterility.
Physicians Total Care is recalling Carisoprodol 350mg tablets because heavy metals and inactive components were found during routine stability testing.